One possible mechanism is that in the presence of high ERBB2 levels, ERBB4 with bound NRG4 may form ERBB2:ERBB4 heterodimers, which possess oncogenic activity, rather than ERBB4:ERBB4 homodimers, which function as tumor suppressors [25,51]. Here, ERBB2 is linked to neoplasm.